| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/03/2011 | CA2293805C Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment |
| 05/03/2011 | CA2265914C Cellulase variants |
| 05/03/2011 | CA2233207C Type cc chemokine-like protein |
| 05/03/2011 | CA2221893C Antibody specific for staphylococcus aureus, and use thereof |
| 05/03/2011 | CA2206509C Novel hedgehog-derived polypeptides |
| 04/29/2011 | CA2741418A1 Detection and modulation of cytochrome c acetylation |
| 04/28/2011 | WO2011050326A1 Microorganisms for the production of aniline |
| 04/28/2011 | WO2011050281A2 A method of controlling plant growth and architecture by controlling expression of gibberellin 2-oxidase |
| 04/28/2011 | WO2011050278A1 Amplification primers with non-standard bases for increased reaction specificity |
| 04/28/2011 | WO2011050271A1 Methods and compositions for expression of transgenes in plants |
| 04/28/2011 | WO2011050262A2 Dual variable domain immunoglobulins and uses thereof |
| 04/28/2011 | WO2011050129A1 Microrna-10 antagonists and microrna-10 targets for use in the treatment of a glioma |
| 04/28/2011 | WO2011050096A2 Methods and compositions for diagnosis and treatment of genetic and retinal disease |
| 04/28/2011 | WO2011050050A2 Use of a high-resolution melting assay to measure genetic diversity |
| 04/28/2011 | WO2011050000A2 Single molecule nucleic acid nanoparticles |
| 04/28/2011 | WO2011049995A1 Homologous recombination in an algal nuclear genome |
| 04/28/2011 | WO2011049956A2 Toxicity-associated genes, genetic variants, and use thereof |
| 04/28/2011 | WO2011049758A1 Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors |
| 04/28/2011 | WO2011049750A1 Multifunctional aptamer-nucleic acid nanostructures for tumor-targeted killing |
| 04/28/2011 | WO2011049627A1 Engineered zinc finger proteins targeting plant genes involved in fatty acid biosynthesis |
| 04/28/2011 | WO2011049590A1 Producing an immune response for reducing the risk of developing brucellosis |
| 04/28/2011 | WO2011049587A1 Transgenic soybean plants and chromosomes |
| 04/28/2011 | WO2011049560A1 Glutamate receptors in nutrient sensing, metabolism, growth and development |
| 04/28/2011 | WO2011049418A2 Novel ginsenoside glycosidase derived from the genus terrabacter, and use thereof |
| 04/28/2011 | WO2011049412A2 Human recombinant monoclonal antibody that specifically binds to vcam-1 and inhibits adhesion and transmigration between leukocytes and endothelial cells |
| 04/28/2011 | WO2011049409A2 Mannose 6-phosphate isomerase, mutants thereof, and use thereof |
| 04/28/2011 | WO2011049350A9 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same |
| 04/28/2011 | WO2011049350A2 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same |
| 04/28/2011 | WO2011049343A2 Methods and kits for the k-ras mutant detection using pna mediated real-tim pcr clamping |
| 04/28/2011 | WO2011049334A2 OsLRP GENE FOR INCREASING PLANT DISEASE RESISTANCE, AND USE THEREOF |
| 04/28/2011 | WO2011049329A2 Method for producing transformed earthworms using earthworm gonad-regeneration capability, transformed earthworms thereof, and method for producing recombinant proteins from transformed earthworm body fluids |
| 04/28/2011 | WO2011049324A2 Analytic method and diagnostic kit for diagnosis of polycystic ovary syndrome |
| 04/28/2011 | WO2011049322A2 Method for detecting methylation of breast cancer-specific methylation marker gene for breast cancer diagnosis |
| 04/28/2011 | WO2011049291A2 Mesenchymal stem cell incorporating a nucleotide sequence coding tgfβ, and uses thereof |
| 04/28/2011 | WO2011049243A1 Transgenic plant having increased biomass and improved environmental stress resistance, and process for production thereof |
| 04/28/2011 | WO2011049239A1 Human erosive rheumatoid arthritis model non-human mammal |
| 04/28/2011 | WO2011049237A1 Biomarkers for predicting therapeutic effect in hyposensitization therapy |
| 04/28/2011 | WO2011049227A1 Modified promoter |
| 04/28/2011 | WO2011049207A1 Moyamoya disease-related gene and utilization of same |
| 04/28/2011 | WO2011049205A1 Method for production of lactic acid by non-sterile fermentation |
| 04/28/2011 | WO2011049157A1 Rapid display method in translational synthesis of peptide |
| 04/28/2011 | WO2011049099A1 Method for producing cancer stem cell |
| 04/28/2011 | WO2011049082A1 INTEGRIN α8Β1-SPECIFIC MONOCLONAL ANTIBODY |
| 04/28/2011 | WO2011049043A1 Screening method utilizing thalidomide-targeting factor |
| 04/28/2011 | WO2011048922A1 Method for detection of glycosaminoglycan, and molecular probe for use in the method |
| 04/28/2011 | WO2011048852A1 Pectin lyase, pectin lyase gene, enzyme preparation, and method for production of single cells of plant tissue |
| 04/28/2011 | WO2011048766A1 Carbonic anhydrase i serving as novel antigen to be used for treatment of autoimmune diseases |
| 04/28/2011 | WO2011048600A1 Generating genotypic variations in plant genomes by gamete infection |
| 04/28/2011 | WO2011048566A1 A means for inducing apomixis in cultivated plants having sexual reproduction and use thereof for the production of completely or partially apomictic plants |
| 04/28/2011 | WO2011048445A1 Inhibitors of guanine exchange factors and their use as anticancer drugs |
| 04/28/2011 | WO2011048248A1 Adjuvant for vaccines, vaccines that comprise said adjuvant and uses thereof |
| 04/28/2011 | WO2011048125A1 Oral delivery of therapeutically effective lna oligonucleotides |
| 04/28/2011 | WO2011048009A1 Plants having enhanced yield-related traits and a method for making the same |
| 04/28/2011 | WO2011047631A1 Proteins or polypeptides with cd137l function and genes encoding the same and uses thereof |
| 04/28/2011 | WO2011047607A1 Plant stress tolerance related protein gmsik1 and encoding gene and use thereof |
| 04/28/2011 | WO2011047531A1 Novel immunological adjuvant and vaccines comprising said adjuvant |
| 04/28/2011 | WO2011047433A1 Method of modifying plant development and productivity |
| 04/28/2011 | WO2011021102A3 Compositions and methods for intramolecular nucleic acid rearrangement |
| 04/28/2011 | WO2011017492A3 Novel eto1 genes and use of same for reduced ethylene and improved stress tolerance in plants |
| 04/28/2011 | WO2011014721A3 Genetically modified rat models for pharmacokinetics |
| 04/28/2011 | WO2011011292A3 Combinatorial methods for optimizing engineered microorganism function |
| 04/28/2011 | WO2011005523A3 Galectin-immunoglobulin chimeric molecules |
| 04/28/2011 | WO2011005363A3 Carbon nanotubes complexed with multiple bioactive agents and methods related thereto |
| 04/28/2011 | WO2010147462A9 Novel stringent selectable markers |
| 04/28/2011 | WO2010141928A3 Isolation and targeted suppression of lignin biosynthetic genes from sugarcane |
| 04/28/2011 | WO2010138973A3 Advanced pathogen detection and screening |
| 04/28/2011 | WO2010138885A3 Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses |
| 04/28/2011 | WO2010138750A3 Generation of genetically corrected disease-free induced pluripotent stem cells |
| 04/28/2011 | WO2010136981A3 Meganuclease variants cleaving the genome of a pathogenic non-integrating virus and uses thereof |
| 04/28/2011 | WO2010036960A8 Methods for treating, diagnosing, and monitoring lupus |
| 04/28/2011 | WO2009060316A3 Hepatitis b virus-binding polypeptides and methods of use thereof |
| 04/28/2011 | WO2008070943A3 Soluble dimerized or oligomerized endostatin |
| 04/28/2011 | US20110099670 Nucleotide sequences coding for cis-aconitic decarboxylase and use thereof |
| 04/28/2011 | US20110099669 Plants having enhanced yield-related traits and a method for making the same |
| 04/28/2011 | US20110099668 Expressing GLK in plants |
| 04/28/2011 | US20110099667 Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding lnt1 polypeptides and homologs thereof |
| 04/28/2011 | US20110099666 Modification of plant lignin content |
| 04/28/2011 | US20110099665 Leafy cotyledon 1 transcriptional activator (lec1) variant polynucleotides and polypeptides compositions and methods of increasing transformation efficiency |
| 04/28/2011 | US20110099664 Producing process of sterile plants, plants obtained by the process, and use of the plants |
| 04/28/2011 | US20110099663 Carrot hybrid 07100375 |
| 04/28/2011 | US20110099662 Corn event tc1507 and methods for detection thereof |
| 04/28/2011 | US20110099661 Soybean Cultivar S080186 |
| 04/28/2011 | US20110099660 Soybean Cultivar S080203 |
| 04/28/2011 | US20110099659 Soybean Cultivar S080189 |
| 04/28/2011 | US20110099658 Soybean Cultivar S080120 |
| 04/28/2011 | US20110099657 Soybean Cultivar S080187 |
| 04/28/2011 | US20110099655 Transgenic Plants |
| 04/28/2011 | US20110099649 Method for performing genetic modification under a drug-free environment and components thereof |
| 04/28/2011 | US20110099648 Recombinant gene which enhances the ability of fish to tolerate low dissolved oxygen stress and the use thereof |
| 04/28/2011 | US20110099646 Green fluorescent protein optimized for expression with self-cleaving polypeptides |
| 04/28/2011 | US20110099644 Mig-6 knockout mice and elucidation of association of mig-6 with early onset degenerative joint disease and role as a tumor suppressor |
| 04/28/2011 | US20110098460 SiRNA Useful to Suppress expression of eIF-5A1 |
| 04/28/2011 | US20110098450 Antibody Molecules |
| 04/28/2011 | US20110098443 Anti-GLP-1R Antibodies and Their Uses |
| 04/28/2011 | US20110098441 Label target and labeling reagents comprising backbones with at least two consecutive peptide bonds |
| 04/28/2011 | US20110098346 Nucleic acid molecule and method of targeting gene expression to gliomas |
| 04/28/2011 | US20110098340 Antisense modulation of bcl2-associated x protein expression |
| 04/28/2011 | US20110098339 C2orf18 as target gene for cancer therapy and diagnosis |
| 04/28/2011 | US20110098338 RNA Interference for the Treatment of Heart Failure |
| 04/28/2011 | US20110098233 Hla-a* 1101-restricted wt1 peptide and pharmaceutical composition comprising the same |